Microclear
Microclear (Suzhou Microclear Medical Instruments) develops ultra-widefield confocal laser ophthalmoscopes and SS-OCT platforms (Apollo and SKY series) used by 1,500+ hospitals and research institutions across 60+ countries for ophthalmic diagnosis and AI-assisted retinal screening.
- Company typePrivate
- Founded2011
- HeadquartersSuzhou, China
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Microclear does
Microclear (Suzhou Microclear Medical Instruments Co., Ltd, 苏州微清医疗器械有限公司) is a Suzhou-headquartered medical device company founded in 2011 that develops ultra-widefield ophthalmic imaging systems built on proprietary confocal laser scanning ophthalmoscopy (SLO) combined with swept-source optical coherence tomography (SS-OCT). The company designs and manufactures hardware platforms used in ophthalmology, optometry, endocrinology, maternal-child health, health check-up centers, and pre-clinical research, with regulatory clearances for China (NMPA), the United States (FDA), and the European Union (CE), plus ISO 13485 quality certification. Its product line includes the Apollo and Apollo Auto ultra-widefield confocal SLO fundus cameras (manual and automated variants), the SKY whole-eye imaging platform launched in November 2024 that synchronizes SLO color, FAF, FFA, ICGA, and SS-OCT modalities in a single scan, and the SKY Lab research variant configured for small-animal imaging.
Microclear firmographics
Firmographics- Name
- Microclear
- Legal name
- Suzhou Microclear Medical Instruments Co.,Ltd
- Website
- https://microcleartech.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Microclear (Suzhou Microclear Medical Instruments) develops ultra-widefield confocal laser ophthalmoscopes and SS-OCT platforms (Apollo and SKY series) used by 1,500+ hospitals and research institutions across 60+ countries for ophthalmic diagnosis and AI-assisted retinal screening.
- Ownership category
- akta.pro rank
Microclear industry classification
Industry- Product category
- Ophthalmic Medical Imaging Equipment
- NAICS
- Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography) (HLAHAJAB)
Keywords
Where Microclear is headquartered
LocationHeadquarters
- HQ city
- Suzhou
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Microclear business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Imaging Hardware Sales: Microclear generates revenue through the sale of ophthalmic imaging equipment including fundus cameras, confocal laser scanning systems, and SS-OCT devices. The revenue model appears to be one-time hardware sales with associated after-sales service and support contracts.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Microclear product offering
Product offeringCore offering
Microclear designs, develops, and manufactures ultra-widefield ophthalmic imaging systems based on proprietary confocal laser scanning ophthalmoscopy (SLO) and swept-source optical coherence tomography (SS-OCT) technologies. Its product portfolio includes the Apollo and Apollo Auto confocal SLO fundus cameras and the SKY/SKY Lab whole-eye imaging platforms, sold to hospitals, eye clinics, and research institutions for retinal disease diagnosis, diabetic retinopathy screening, and pre-clinical ophthalmic research.
Product overview
Microclear offers a portfolio of ophthalmic imaging products centered around ultra-widefield confocal laser scanning technology. The product line consists of Apollo (manual) and Apollo Auto (automated) for ultra-widefield retinal imaging, and SKY and SKY Lab for whole-eye imaging combining SLO and SS-OCT technologies. Apollo/Apollo Auto provide multimodal fundus imaging (color, FAF, FFA, ICGA) with up to 265° field of view. SKY extends this with integrated swept-source OCT for synchronized structural and flat retinal imaging. SKY Lab serves the research market with animal imaging capabilities. All products share core confocal laser scanning technology with AI-enabled automation features.
Differentiator
Problem solved
Functional benefit
Brands
- Apollo: Ultra-widefield Confocal SLO fundus camera - manual version with multi-modality imaging capabilities including Color Fundus Photography, Infrared, Red Free, FAF, FFA, and ICGA.
- Apollo Auto
- SKY
- SKY Lab
Products and services
- Apollo Ultra-widefield manual Confocal Laser Scanning Ophthalmoscopy (SLO) retinal imaging system for ophthalmology departments, offering Color Fundus Photography, Infrared, Red Free, FAF, FFA, and ICGA modalities with up to 5μm optical resolution and up to 265° montage field of view.
- Apollo Auto Automated ultra-widefield Confocal SLO retinal imaging system with Auto-alignment, Auto-focus, and Auto-acquisition features, providing the same multi-modality imaging (Color, Infrared, FAF, FFA, ICGA) as Apollo with streamlined workflow for hospitals and high-volume screening centers.
- SKY Whole-eye imaging platform combining confocal SLO and swept-source OCT (SS-OCT) that produces synchronized ultra-widefield COLOR/FAF/FFA/ICGA and SS-OCT images in a single scan for comprehensive ophthalmic diagnosis in hospitals and advanced eye clinics.
- SKY Lab Research-grade whole-eye imaging platform that combines confocal laser scanning with SS-OCT for cellular-level retinal observation and pathological analysis in animal models (mouse, rabbit, monkey, dog, pig), targeted at life sciences and pre-clinical research institutions.
Quantifiable outcome
- Ultra-widefield imaging: 135° single shot, up to 265° with montage; Optional 165° FOV
- +3 more outcomes
Companies that use Microclear
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles3 records
Microclear technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature8 records
Microclear partnerships and signals
Strategic signalScale indicators6 records
Recent moves10 records
Expansion highlights5 records
Microclear competitors and assessment
Company assessmentDirect peers
- Topcon Healthcare: Topcon's DRI OCT (swept-source OCT), Maestro, and TRC fundus camera systems are sold into the same ophthalmology/endocrinology screening segments Microclear targets with SKY and Apollo. Direct overlap on SS-OCT and fundus photography makes Topcon one of the most relevant direct peers.
- Carl Zeiss Meditec: Zeiss Meditec's CIRRUS HD-OCT and Clarus fundus camera cover the multimodal retinal imaging segments where Microclear sells Apollo and SKY. As one of the largest ophthalmic device manufacturers globally, Zeiss is a primary incumbent competitor across premium ophthalmology hospital purchasing.
- Optos (Nikon): Optos pioneered ultra-widefield retinal imaging (Panoramic 200, California, Monaco) using scanning laser ophthalmoscopy — exactly the modality Microclear competes in with Apollo. Now part of Nikon, Optos is the closest direct competitor to Microclear's ultra-widefield confocal SLO platform and targets the same ophthalmology and optometry end-customers worldwide.
- Heidelberg Engineering: Heidelberg Engineering's Spectralis OCT and HRA2 confocal SLO/angiography systems are the gold-standard multimodal retinal imaging devices used by hospital ophthalmology departments globally. Microclear's Apollo and SKY directly compete against Heidelberg in confocal SLO + OCT combined imaging, especially in FFA/ICGA workflows.
- Nidek Co., Ltd. Nidek produces the Mirante (SLO + OCT multimodal) and other fundus imaging devices that compete with Microclear's Apollo and SKY, particularly in Asian and European ophthalmology markets. Its combined SLO/OCT platform overlaps directly with Microclear's synchronization value proposition.
- Canon Medical Systems (Ophthalmic): Canon's CX-1, Xephilio OCT, and retinal cameras serve the same ophthalmology and diabetic retinopathy screening segments as Microclear. Canon's strength in non-mydriatic cameras and global distribution makes it a direct competitor in screening-oriented clinical workflows.
Emerging players
- Optopol Technology (now part of Tomey/Canon): Optopol is a Polish OCT manufacturer (REVO, SOCT Copernicus) with strong price-performance positioning in mid-tier ophthalmic clinics. They compete with Microclear's SKY SS-OCT specifically in cost-sensitive markets where Microclear's premium positioning may be a barrier.
- Intalight Imaging: Intalight is a Chinese OCT developer (SS-OCT, Angio OCT) that competes directly with Microclear in both domestic ophthalmic imaging and emerging overseas markets, particularly targeting similar endocrinology/DR-screening use cases with comparable technology positioning.
- Moptim (MOPTIM Imaging): Moptim (formerly Superlum) is a Chinese manufacturer of OCT and confocal imaging systems. As a domestic Chinese peer with overlapping SLO/OCT technology, Moptim competes with Microclear for the same Chinese hospital procurement budget and represents a credible emerging alternative.
Broad incumbents
- Tomey Corporation: Tomey produces a broad portfolio of ophthalmic diagnostic devices (OCT, specular microscopy, topography, perimetry) that overlaps with parts of Microclear's Apollo/SKY offering. As a Japanese incumbent with global distribution, Tomey is a meaningful adjacent peer in the ophthalmic imaging category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Microclear social profiles
Digital presenceMicroclear compliance and trust
Trust signalCompliance4 records
Microclear financial estimates
Financial estimateRevenue estimate
Valuation estimate
Microclear leadership team
Management profileNumber of profiles
Profiles1 record
Microclear funding detail
Funding detailFunding overview
Funding rounds5 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Microclear M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Microclear
What does Microclear do?
Microclear designs, develops, and manufactures ultra-widefield ophthalmic imaging systems based on proprietary confocal laser scanning ophthalmoscopy (SLO) and swept-source optical coherence tomography (SS-OCT) technologies. Its product portfolio includes the Apollo and Apollo Auto confocal SLO fundus cameras and the SKY/SKY Lab whole-eye imaging platforms, sold to hospitals, eye clinics, and research institutions for retinal disease diagnosis, diabetic retinopathy screening, and pre-clinical ophthalmic research.
Is Microclear a public or private company?
Microclear is a private company. It is classified as venture growth investor backed and is currently operating.
When was Microclear founded?
Microclear was founded in 2011. It employs 51 to 100 people.
Where is Microclear based?
Microclear is headquartered in Suzhou, China, in the Asia region.
How does Microclear make money?
One revenue line is on record: medical Imaging Hardware Sales.
Who are Microclear's main competitors?
Direct peers on record are Topcon Healthcare, Carl Zeiss Meditec, Optos (Nikon), Heidelberg Engineering, Nidek Co., Ltd. and Canon Medical Systems (Ophthalmic). Emerging players are Optopol Technology (now part of Tomey/Canon), Intalight Imaging and Moptim (MOPTIM Imaging). Tomey Corporation is listed as a broad incumbent.
Does Microclear have an API?
No public API is recorded for Microclear.
What industry is Microclear in?
Microclear's product category is Ophthalmic Medical Imaging Equipment. Its primary akta.pro industry code is HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography). Its NAICS code is 339115 and its SIC code is 3841.